ArticleTranslational cancer research2020

PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study.

Qing Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.